Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NYT Stock Summary
In the News
NYT Financial details
Company Rating
Strong Buy
Market Cap
6.94B
Income
232.39M
Revenue
2.43B
Book val./share
10.71
Cash/share
2.74
Dividend
0.46
Dividend %
1.08%
Employees
5.9K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
30.05
Forward P/E
-
PEG
8.22
P/S
2.86
P/B
3.96
P/C
15.24
P/FCF
20.54
Quick Ratio
1.14
Current Ratio
1.28
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
1.42
EPS next Y
-
EPS next Q
-
EPS this Y
35.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.91%
Revenue last 5Y
6.01%
Revenue Q/Q
13.01%
EPS Q/Q
103.03%
-
-
-
-
SMA20
-2.2%
SMA50
-11.82%
SMA100
-4.58%
Inst Own
56.7%
Inst Trans
0.63%
ROA
9%
ROE
14%
ROC
0.13%
Gross Margin
48%
Oper. Margin
11%
Profit Margin
10%
Payout
30%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
35.06-49.87
52W High
-14.76%
52W Low
+19.34%
RSI
33.64
Rel Volume
0.57
Avg Volume
1.3M
Volume
738.72K
Perf Week
-4.02%
Perf Month
-2.88%
Perf Quarter
2.33%
Perf Half Y
-4.59%
-
-
-
-
Beta
1.011
-
-
Volatility
0.76%, 0.63%
Prev Close
0.38%
Price
41.77
Change
-1.88%
NYT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-29 | 2020-12-27 | 2021-12-26 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 10.91 | 10.68 | 12.36 | 13.83 | 14.73 | |
Net income per share | 0.84 | 0.6 | 1.31 | 1.04 | 1.41 | |
Operating cash flow per share | 1.14 | 1.78 | 1.6 | 0.9 | 2.19 | |
Free cash flow per share | 0.87 | 1.58 | 1.4 | 0.68 | 2.05 | |
Cash per share | 2.6 | 3.56 | 3.94 | 2.08 | 2.74 | |
Book value per share | 7.06 | 7.94 | 9.16 | 9.58 | 10.7 | |
Tangible book value per share | 6.23 | 6.93 | 8.1 | 5.21 | 6.46 | |
Share holders equity per share | 7.06 | 7.94 | 9.16 | 9.58 | 10.7 | |
Interest debt per share | 0.4 | 0.37 | 0.44 | 0.66 | 0.33 | |
Market cap | 5.34B | 8.62B | 8B | 5.42B | 8.07B | |
Enterprise value | 5.16B | 8.39B | 7.74B | 5.25B | 7.83B | |
P/E ratio | 38.14 | 86.1 | 36.37 | 31.15 | 34.73 | |
Price to sales ratio | 2.95 | 4.83 | 3.86 | 2.35 | 3.33 | |
POCF ratio | 28.11 | 28.93 | 29.73 | 35.95 | 22.38 | |
PFCF ratio | 36.95 | 32.71 | 34.12 | 47.63 | 23.88 | |
P/B Ratio | 4.55 | 6.5 | 5.2 | 3.39 | 4.58 | |
PTB ratio | 4.55 | 6.5 | 5.2 | 3.39 | 4.58 | |
EV to sales | 2.85 | 4.7 | 3.73 | 2.28 | 3.23 | |
Enterprise value over EBITDA | 22.36 | 35.18 | 23.24 | 13.4 | 19.52 | |
EV to operating cash flow | 27.19 | 28.15 | 28.78 | 34.87 | 21.72 | |
EV to free cash flow | 35.74 | 31.83 | 33.03 | 46.2 | 23.18 | |
Earnings yield | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | |
Free cash flow yield | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | |
Debt to equity | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | |
Debt to assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Net debt to EBITDA | -0.76 | -0.98 | -0.77 | -0.41 | -0.59 | |
Current ratio | 1.64 | 1.72 | 1.7 | 1.15 | 1.28 | |
Interest coverage | 45.96 | 242.44 | 348.55 | 7.61 | 301.75 | |
Income quality | 1.36 | 2.95 | 1.22 | 0.87 | 1.55 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.23 | 0.38 | 0.21 | 0.33 | 0.3 | |
Sales general and administrative to revenue | 0.19 | 0.13 | 0.12 | 0.13 | 0.13 | |
Research and developement to revenue | 0.06 | 0.07 | 0.08 | 0.09 | 0.09 | |
Intangibles to total assets | 0.07 | 0.07 | 0.06 | 0.29 | 0.26 | |
Capex to operating cash flow | -0.24 | -0.12 | -0.13 | -0.25 | -0.06 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.02 | -0.01 | |
Capex to depreciation | -0.67 | -0.49 | -0.52 | -0.4 | -0.24 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Graham number | 11.57 | 10.35 | 16.43 | 14.98 | 18.43 | |
ROIC | 0.12 | 0.11 | 0.12 | 0.13 | 0.13 | |
Return on tangible assets | 0.07 | 0.05 | 0.09 | 0.1 | 0.12 | |
Graham Net | -1.86 | -1.39 | -1.02 | -2.37 | -1.91 | |
Working capital | 279.14M | 349.09M | 393.56M | 84.47M | 170.09M | |
Tangible asset value | 1.04B | 1.16B | 1.37B | 868.61M | 1.06B | |
Net current asset value | -198.44M | -143.74M | -70.68M | -278.11M | -169.72M | |
Invested capital | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | |
Average receivables | 217.93M | 198.55M | 208.3M | 225.22M | 231.76M | |
Average payables | 114.06M | 119.86M | 125.12M | 120.86M | 115.79M | |
Average inventory | 27.22M | 29.29M | 31.34M | 44.03M | 27.43M | |
Days sales outstanding | 42.98 | 37.59 | 40.97 | 34.4 | 37.01 | |
Days payables outstanding | 60.24 | 46.81 | 44.62 | 34.61 | 31.97 | |
Days of inventory on hand | 15.03 | 11.21 | 11.66 | 16.56 | 0 | |
Receivables turnover | 8.49 | 9.71 | 8.91 | 10.61 | 9.86 | |
Payables turnover | 6.06 | 7.8 | 8.18 | 10.54 | 11.42 | |
Inventory turnover | 24.28 | 32.56 | 31.31 | 22.04 | 0 | |
ROE | 0.12 | 0.08 | 0.14 | 0.11 | 0.13 | |
Capex per share | -0.27 | -0.21 | -0.21 | -0.22 | -0.14 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.03 | 3.4 | 3.59 | 3.64 | 4.11 | |
Net income per share | 0.43 | 0.14 | 0.28 | 0.33 | 0.67 | |
Operating cash flow per share | 0.4 | 0.31 | 0.42 | 0.63 | 0.83 | |
Free cash flow per share | 0.34 | 0.27 | 0.39 | 0.6 | 0.79 | |
Cash per share | 2.1 | 2.27 | 2.53 | 2.42 | 2.74 | |
Book value per share | 9.65 | 9.55 | 9.75 | 10.05 | 10.71 | |
Tangible book value per share | 5.24 | 5.16 | 5.4 | 5.77 | 6.46 | |
Share holders equity per share | 9.65 | 9.55 | 9.75 | 10.05 | 10.71 | |
Interest debt per share | 0.43 | -0.99 | -0.95 | -0.95 | 0.32 | |
Market cap | 5.38B | 6.41B | 6.49B | 6.78B | 8.06B | |
Enterprise value | 5.21B | 6.18B | 6.24B | 6.54B | 7.83B | |
P/E ratio | 18.99 | 71.84 | 34.82 | 31.62 | 18.35 | |
Price to sales ratio | 8.05 | 11.44 | 10.98 | 11.33 | 11.93 | |
POCF ratio | 81.87 | 126.44 | 93.94 | 65 | 59.08 | |
PFCF ratio | 95.13 | 143.35 | 100.96 | 68.78 | 61.85 | |
P/B Ratio | 3.36 | 4.07 | 4.04 | 4.1 | 4.57 | |
PTB ratio | 3.36 | 4.07 | 4.04 | 4.1 | 4.57 | |
EV to sales | 7.81 | 11.02 | 10.56 | 10.94 | 11.58 | |
Enterprise value over EBITDA | 31.24 | 126.77 | 60.53 | 72.68 | 52.97 | |
EV to operating cash flow | 79.4 | 121.8 | 90.38 | 62.74 | 57.34 | |
EV to free cash flow | 92.26 | 138.09 | 97.14 | 66.4 | 60.04 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Debt to equity | 0.04 | -0.1 | -0.1 | -0.09 | 0.03 | |
Debt to assets | 0.03 | -0.07 | -0.06 | -0.06 | 0.02 | |
Net debt to EBITDA | -0.97 | -4.83 | -2.38 | -2.62 | -1.6 | |
Current ratio | 1.15 | 1.17 | 1.27 | 1.19 | 1.28 | |
Interest coverage | 59.75 | 112.5 | 235.34 | 227.03 | 479.81 | |
Income quality | 0.93 | 2.27 | 1.48 | 1.95 | 1.24 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.21 | 0.68 | 0.39 | 0.34 | 0.16 | |
Sales general and administrative to revenue | 0.12 | 0.14 | 0.12 | 0.14 | 0.12 | |
Research and developement to revenue | 0.08 | 0.1 | 0.09 | 0.1 | 0.09 | |
Intangibles to total assets | 0.29 | 0.29 | 0.29 | 0.28 | 0.26 | |
Capex to operating cash flow | -0.14 | -0.12 | -0.07 | -0.06 | -0.04 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.38 | -0.26 | -0.2 | -0.24 | -0.26 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 9.63 | 5.39 | 7.87 | 8.58 | 12.68 | |
ROIC | 0.06 | 0.01 | 0.03 | 0.03 | 0.05 | |
Return on tangible assets | 0.04 | 0.01 | 0.03 | 0.03 | 0.05 | |
Graham Net | -2.39 | -2.23 | -1.85 | -2.08 | -1.92 | |
Working capital | 84.47M | 93.95M | 142.72M | 104.08M | 170.09M | |
Tangible asset value | 868.61M | 851.67M | 889.39M | 949.12M | 1.06B | |
Net current asset value | -278.11M | -261.09M | -197.08M | -233.2M | -169.72M | |
Invested capital | 0.04 | -0.1 | -0.1 | -0.09 | 0.03 | |
Average receivables | 190.54M | 191.76M | 162.48M | 161.51M | 205.01M | |
Average payables | 117.09M | 118.33M | 116.42M | 115.3M | 118.36M | |
Average inventory | 56.8M | 56.61M | 59.63M | 58.78M | 28.33M | |
Days sales outstanding | 29.33 | 26.64 | 24.22 | 24.67 | 32.74 | |
Days payables outstanding | 31.07 | 35.79 | 32.18 | 34.65 | 30.68 | |
Days of inventory on hand | 14.87 | 17.12 | 17.69 | 16.39 | 0 | |
Receivables turnover | 3.07 | 3.38 | 3.72 | 3.65 | 2.75 | |
Payables turnover | 2.9 | 2.52 | 2.8 | 2.6 | 2.93 | |
Inventory turnover | 6.05 | 5.26 | 5.09 | 5.49 | 0 | |
ROE | 0.04 | 0.01 | 0.03 | 0.03 | 0.06 | |
Capex per share | -0.06 | -0.04 | -0.03 | -0.03 | -0.04 |
NYT Frequently Asked Questions
What is The New York Times Company stock symbol ?
The New York Times Company is a US stock , located in New york of Ny and trading under the symbol NYT
What is The New York Times Company stock quote today ?
The New York Times Company stock price is $41.77 today.
Is The New York Times Company stock public?
Yes, The New York Times Company is a publicly traded company.